Akèy › Maladi Dijestif › Washington › Seattle
Etid klinik pou Maladi Dijestif nan Seattle, WA
5 etid pou Maladi Dijestif ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- University of Washington School Medicine, Seattle
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center, Seattle
- ak 1 plis
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Seattle, Seattle
- Bremerton, Bremerton · 14 mi lwen
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
Etid Maladi Dijestif nan lòt vil
- New York City, NY8 etid
- Chicago, IL8 etid
- Houston, TX8 etid
- Boston, MA6 etid
- Washington, DC6 etid
- San Diego, CA6 etid
- Durham, NC6 etid
- St. Louis, MO5 etid
- Nashville, TN5 etid
- San Antonio, TX5 etid
- Jacksonville, FL5 etid
- Tyler, TX5 etid
Lòt etid nan Seattle
- Kansè Poumon ki pa ti selil53 etid
- Kansè (tout kalite)49 etid
- Kansè pwostat44 etid
- Leksemi mieloïd egi40 etid
- Kansè nan tete40 etid
- Kansè Metastatik39 etid
- Kansè kolorektal34 etid
- Kansè poumon33 etid
- Kansè ovè31 etid
- Myelom Miltip22 etid
- Kansè pankreyas22 etid
- Kansè vejik21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.